This legislation renews and updates federal efforts to prevent overdoses, expand treatment, and support recovery. It boosts funding for programs run by states, Tribes, and local groups; strengthens care for pregnant and postpartum women; builds support for families affected by fetal alcohol spectrum disorders (FASD); and improves youth trauma monitoring and community recovery supports . It also promotes safer handling and assessment of opioids, allows grants to cover fentanyl/xylazine test strips, and adds cybersecurity protections for the 9-8-8 Suicide & Crisis Lifeline .

Key changes include more funding from fiscal years 2026–2030: overdose prevention grants ($505.6M/year), prenatal/postnatal health ($4.25M/year), residential treatment for pregnant/postpartum women ($38.931M/year), SUD workforce loan repayment ($40M/year), youth/adult trauma monitoring ($9M/year), communities of recovery ($7M/year), and FASD programs ($12.5M/year) . It asks FDA to publish a plan within one year to assess approved opioid pain medicines and support nonaddictive treatments; HHS to issue guidance within one year on at‑home drug disposal; and GAO to study 9‑8‑8 cybersecurity within 180 days fileciteturn0file